Recent studies have reported that achieving CD4+ T-cell counts of >50 cells/μL on two consecutive assessments within 100 days post-HCT was associated with improved OS and EFS and reduced NRM, but no association with acute GVHD was found (34). Here, CD4 is linked to acute graft versus host disease.